The ability of enterotoxin-based mucosal adjuvants to induce CD8(+) MHC: cl
ass I-restricted CTL responses to a codelivered bystander Ag was examined.
Escherichia coli heat-labile toxin (LT), or derivatives of LT carrying muta
tions in the A subunit (LTR72, LTK63), were tested in parallel with cholera
toxin (CT) or a fusion protein consisting of the Al subunit of CT fused to
the Ig binding domain of Staphylococcus aureus protein A (called CTA1-DD),
Intranasal (i.n.) immunization of C57BL/6 mice with CT, CTA1-DD, LT, LTR72
, LTK63, but not rLT-B, elicited MHC class I-restricted CD8(+) T cell respo
nses to coadministered OVA or the OVA CTL peptide SIINFEKL (OVA(257-264)),
CT, LT, and LTR72 also induced CTL responses to OVA after s.c. or oral coim
munization whereas LTK63 only activated responses after s.c. coimmunization
. rLT-B was unable to adjuvant CTL responses to OVA or OVA(257-264) adminis
tered by any route, Mice treated with an anti-CD4 mAb to deplete CD4(+) T c
ells mounted significant OVA-specific CTL responses after i.n. coadministra
tion of LT with OVA or OVA(257-264) Both Cr-51 release assays and IFN-gamma
enzyme-linked immunospot assays indicated that IFN-gamma(-/-) and IL-12 p4
0(-/-) gene knockout mice developed CTL responses equivalent to those detec
ted in normal C57BL/6 mice, The results highlight the versatility of toxin-
based adjuvants and suggest that LT potentiates CTL responses independently
of IL-12 and IFN-gamma and probably by a mechanism unrelated to cross-prim
ing.